Robert Rissmann (R Rissmann)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Top Venues

British journal of clinical pharmacology

Clinical and translational science

The British journal of dermatology

Experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan J Jodl, Wouter Ten Voorde, Stefan Klein, Andrea Wagenfeld, Frank S Zollmann, Maximilian Feldmüller, Naomi B Klarenbeek, Digna T de Bruin, Manon A A Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and translational science 17 (3) (2024)
Stefan J Jodl, Wouter Ten Voorde, Stefan Klein, Andrea Wagenfeld, Frank S Zollmann, Maximilian Feldmüller, Naomi B Klarenbeek, Digna T de Bruin, Manon A A Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and translational science 17 (3) (2024)
Stefan J Jodl, Wouter Ten Voorde, Stefan Klein, Andrea Wagenfeld, Frank S Zollmann, Maximilian Feldmüller, Naomi B Klarenbeek, Digna T de Bruin, Manon A A Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and translational science 17 (3) (2024)
Wouter Ten Voorde, Mahdi Saghari, Jiry Boltjes, Marieke L de Kam, Ahnjili Zhuparris, Gary Feiss, Thomas P Buters, Errol P Prens, Jeffrey Damman, Tessa Niemeyer van der Kolk, Matthijs Moerland, Jacobus Burggraaf, Martijn Bastiaan Adriaan van Doorn, Robert Rissmann
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers. Experimental dermatology (2023)
Bertine W Huisman, Lauren E H Nené, Feeke L L Linders, Tom K Gambrah, Tessa Niemeyer van der Kolk, Marieke L de Kam, Jan Nico Bouwes Bavinck, Jacobus Burggraaf, Gary Feiss, Robert Rissmann
No effect of topical digoxin and furosemide for patients with actinic keratosis. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Deepak Mukesh Wieshwaykumar Balak, Robert Rissmann
Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic wave. The British journal of dermatology 187 (5) (2022)
Laura M de Jong, Sylvia D Klomp, Nicoline Treijtel, Robert Rissmann, Jesse Joachim Swen, Martijn L Manson
A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling. British journal of clinical pharmacology 88 (10) (2022)
Thomas P Buters, Pieter W Hameeteman, Iris M E Jansen, Floris C van Hindevoort, Wouter Ten Voorde, Edwin Florencia, Michelle Osse, Marieke L de Kam, Hendrika W Grievink, Mascha Schoonakker, Amit A Patel, Simon Yona, Derek W Gilroy, Erik Lubberts, Jeffrey Damman, Gary Feiss, Robert Rissmann, Manon A A Jansen, Jacobus Burggraaf, Matthijs Moerland
Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers. British journal of clinical pharmacology (2021)
Justin Jacobse, Wouter Ten Voorde, Anushka Tandon, Stefan G Romeijn, Hendrika W Grievink, Koen van der Maaden, Michiel Joost van Esdonk, Dirk Jan A R Moes, Floris Loeff, Karien Bloem, Annick de Vries, Theo Rispens, Gertjan Wolbink, Marieke de Kam, Dimitrios Ziagkos, Matthijs Moerland, Wim Jiskoot, Joke Bouwstra, Jacobus Burggraaf, Lenneke Schrier, Robert Rissmann, Rebecca Ten Cate
Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial. British journal of clinical pharmacology 87 (8) (2021)
Robert Rissmann, Rob G J A Zuiker
Commentary on "Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies" by Sievers et al. British journal of clinical pharmacology 87 (7) (2021)
Mahdi Saghari, Pim Gal, Dimitrios Ziagkos, Jacobus Burggraaf, John F Powell, Nuala Brennan, Robert Rissmann, Martijn B A van Doorn, Matthijs Moerland
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man. British journal of clinical pharmacology 87 (4) (2020)
Melanie Rijsbergen, Rianne Rijneveld, Marina Todd, Gary L Feiss, Stijn T P Kouwenhoven, Koen D Quint, Dirk C J G van Alewijk, Maurits N C de Koning, Erica S Klaassen, Jacobus Burggraaf, Robert Rissmann, Mariëtte I E van Poelgeest
Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions. British journal of clinical pharmacology 86 (11) (2020)
Robert Rissmann, Matthijs Moerland, Martijn B A van Doorn
Blueprint for mechanistic, data-rich early phase clinical pharmacology studies in dermatology. British journal of clinical pharmacology 86 (6) (2020)
Rikje Ruiter, Jacobus Burggraaf, Robert Rissmann
Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database. British journal of clinical pharmacology 85 (4) (2019)
Melanie Rijsbergen, Tessa Niemeyer van der Kolk, G Hogendoorn, S Kouwenhoven, C Lemoine, E S Klaassen, M de Koning, S Beck, Jan Nico Bouwes Bavinck, G Feiss, Jacobus Burggraaf, Robert Rissmann
A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts. The British journal of dermatology 180 (5) (2019)
Robert Rissmann, Elemer Szabadi
Spotlight Commentary: How to prove pharmacology of immunomodulatory drugs in a phase 1 trial? British journal of clinical pharmacology 85 (7) (2019)
Geert Labots, Aubrey Jones, Saco J de Visser, Robert Rissmann, Jacobus Burggraaf
Gender differences in clinical registration trials: is there a real problem? British journal of clinical pharmacology 84 (4) (2018)
Tessa Niemeyer van der Kolk, H E C van der Wall, C Balmforth, M B A Van Doorn, Robert Rissmann
A systematic literature review of the human skin microbiome as biomarker for dermatological drug development. British journal of clinical pharmacology 84 (10) (2018)
B H E Jansen, G W Disselhorst, Tim Schutte, B Jansen, Robert Rissmann, M C Richir, C J P W Keijsers, F H M Vanmolkot, A Maassen van den Brink, C Kramers, A M Vondeling, G J H Dumont, I de Waard-Siebinga, M A Van Agtmael, J Tichelaar
Essential diseases in prescribing: A national Delphi study towards a core curriculum in pharmacotherapy education. British journal of clinical pharmacology 84 (11) (2018)